Clinical Trial Update: rhTSH-Thyroid Ablation With 1850 MBq of 131I

View source ↗

Summary

A completed clinical trial evaluated thyroid cancer ablation using recombinant human TSH with 1850 MBq of Iodine-131.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Iodine-131 (Iodine-131)
• Thyrogen (thyrotropin alfa)

Snippet

Sponsor: University of Siena | Conditions: Thyroid Cancer | Status: COMPLETED